Jacobs Levy Equity Management, Inc Molecular Templates, Inc. Transaction History

Jacobs Levy Equity Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.81 - $3.43 $35,646 - $150,947	-44,008 Reduced 12.07%	320,745 $292,000
Q1 2022 May 16, 2022	BUY	$2.27 - $4.13 $411,049 - $747,856	181,079 Added 98.59%	364,753 $1.26 Million
Q4 2021 Feb 14, 2022	SELL	$3.37 - $6.87 $30,653 - $62,489	-9,096 Reduced 4.72%	183,674 $720,000
Q3 2021 Nov 15, 2021	SELL	$5.78 - $7.86 $211,917 - $288,179	-36,664 Reduced 15.98%	192,770 $1.29 Million
Q2 2021 Aug 16, 2021	BUY	$7.82 - $12.44 $1.79 Million - $2.85 Million	229,434 New	229,434 $1.79 Million

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $10.1M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.